07:37 AM EDT, 04/30/2024 (MT Newswires) -- Aurora Cannabis Inc. ( ACB ) , the Canadian based global medical cannabis company, in conjunction with MedReleaf Australia, announced Tuesday the expansion of its portfolio with the introduction of a new range of premium dried cannabis flower products. ACB was at last look up 0.15% in US premarket trade, having lost near 6% in regular trade in the United States and Canada yesterday.

Now available for doctors to prescribe to patients in Australia , the new products developed by Aurora and manufactured at its EU-GMP and TGA-GMP certified facility, will be distributed by MedReleaf Australia, a distributor of medical cannabis products holding the second position in the Australian market, according to a statement.